|
SP100 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.307500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.490000E-01 |
| Normal-vs-Stage2 |
1.575550E-01 |
| Normal-vs-Stage3 |
1.258570E-01 |
| Normal-vs-Stage4 |
3.522500E-02 |
| Stage1-vs-Stage2 |
4.358000E-01 |
| Stage1-vs-Stage3 |
3.460600E-01 |
| Stage1-vs-Stage4 |
1.284420E-01 |
| Stage2-vs-Stage3 |
9.734200E-01 |
| Stage2-vs-Stage4 |
4.766400E-01 |
| Stage3-vs-Stage4 |
4.632200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.034400E-01 |
| Normal-vs-AfricanAmerican |
4.535800E-02 |
| Normal-vs-Asian |
1.207400E-01 |
| Caucasian-vs-AfricanAmerican |
1.594580E-01 |
| Caucasian-vs-Asian |
3.663600E-02 |
| AfricanAmerican-vs-Asian |
1.861600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.301400E-01 |
| Normal-vs-Female |
3.081800E-02 |
| Male-vs-Female |
1.830250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.934000E-01 |
| Normal-vs-Extreme_Weight |
3.653600E-01 |
| Normal-vs-Obese |
7.612200E-02 |
| Normal-vs-Extreme_Obese |
6.814600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.236400E-01 |
| Normal_Weight-vs-Obese |
2.024200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.003600E-01 |
| Extreme_Weight-vs-Obese |
2.899800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.906800E-01 |
| Obese-vs-Extreme_Obese |
5.483200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.209940E-04 |
| Normal-vs-Age(41-60Yrs) |
1.758150E-02 |
| Normal-vs-Age(61-80Yrs) |
7.942600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.069000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.740260E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.392100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.344000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.381720E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.798400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.153200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.103030E-01 |
| Normal-VS-Type2 PRCC |
7.040600E-01 |
| Normal-VS-KIRP CIMP |
8.46290000300343E-08 |
| Normal-VS-Unclassified PRCC |
1.898480E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.260000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.23649999994591E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.477170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.09980000007459E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
3.561100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.094230E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.119600E-01 |
| Normal-vs-N1 |
1.395160E-03 |
| Normal-vs-N2 |
3.398000E-01 |
| N0-vs-N1 |
1.113910E-02 |
| N0-vs-N2 |
6.059600E-01 |
| N1-vs-N2 |
4.471800E-01 |
|
|
